We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, reported impressive fourth-quarter fiscal 2020 results. Further, both top and bottom lines improved year over year. Results gained from a sudden spike in demand for household cleaning, personal health and cleansing products, mostly in North America and China, stemming from the ongoing COVID-19 pandemic.
Procter & Gamble’s core earnings of $1.16 per share rose 5% year over year and outpaced the Zacks Consensus Estimate of $1.01 on the back of sturdy sales growth and improved operating margin. Meanwhile, currency-neutral core earnings per share (EPS) increased 11%.
The company reported net sales of $17,698 million, increasing 4% year over year and surpassing the Zacks Consensus Estimate of $16,952 million. The company mix to net sales growth was 1% year over year.
Procter Gamble Company The Price, Consensus and EPS Surprise
On an organic basis (excluding the impact of acquisitions, divestitures and foreign exchange), revenues moved up 6% based on a 3% rise in organic shipment volume. Further, sales inched up 2% owing to higher pricing.
Moreover, all of the company’s business segments, except Grooming, reported growth in organic sales. Organic sales moved up 3% in the Beauty segment, 2% in Health Care, 14% in Fabric & Home Care and 5% in the Baby, Feminine and Family Care segment. However, the metric declined 1% in the Grooming division.
Net sales in the Fabric & Home Care, and Baby, Feminine and Family Care segments rose 11% and 3%, respectively. However, net sales in the Health Care and Grooming segments declined 1% and 5%, respectively. For the Beauty segment, sales remained flat year over year.
Margins
In the reported quarter, core gross margin expanded 210 basis points (bps) year over year to 49.5%, including 40 bps of adverse impacts of foreign currency. On a currency-neutral basis, core gross margin expanded 250 bps owing to benefits from gross productivity savings, higher pricing and commodity cost declines. The uptick was partly offset by unfavorable product mix, manufacturing and logistics expenses and other headwinds.
Core selling, general and administrative expenses (SG&A), as a percentage of sales, increased 70 bps to 29.8%. The metric expanded 50 bps on a currency-neutral basis. This can be attributable to gains from the sale of real estate, increased marketing investments, rise in costs related to wage inflation and incentive compensation. These factors were more than offset by savings related to overhead and marketing expenses.
Moreover, core operating margin expanded 140 bps. On a currency-neutral basis, the metric improved 190 bps, driven by 440 bps of total productivity cost savings.
Financials
Procter & Gamble ended the reported quarter with cash and cash equivalents of $16,181 million, long-term debt of $23,537 million and total shareholders’ equity of $46,878 million.
Cash flow from operating activities amounted to $17,403 million for fiscal 2020, with operating cash flow of $4.8 billion in the fiscal fourth quarter. Moreover, free cash flow productivity was 114%.
Furthermore, the company returned $15.2 billion of cash to its shareholders in fiscal 2020. This included dividend payouts worth $7.8 billion and share buybacks of $7.4 billion.
Fiscal 2021 Guidance
Management issued fiscal 2021 guidance. Notably, the company anticipates sales growth of 1-3%, with organic sales growth of 2-4%. Unfavorable currency is expected to affect sales by 1% in fiscal 2021. Apart from these, capital expenditure is envisioned to be 4-5% of fiscal 2021 sales.
Further, earnings on a reported basis are likely to witness growth of 6-10%. Core earnings for fiscal 2021 are projected to grow 3-7%. This view takes into account an after-tax headwind of $300 million due to currency woes, which are likely to be more than offset by a $275-million after-tax benefit related to reduced commodity costs. Also, elevated interest costs and soft interest income to the tune of $150 million are expected to hurt fiscal 2021 results.
Adjusted free cash flow productivity is estimated to be 90%. In addition to this, the company anticipates dividend payments of $8 billion and share repurchases of $6-$8 billion in fiscal 2021.
Price Performance
We note that shares of this Zacks Rank #2 (Buy) company have gained 10.4% in the past year compared with the industry’s 13.6% growth.
The Clorox Company (CLX - Free Report) has a long-term earnings growth rate of 5.9%. The stock presently carries a Zacks Rank #2.
The Kraft Heinz Company (KHC - Free Report) , with a long-term earnings growth rate of 6%, currently carries a Zacks Rank #2.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
Procter & Gamble (PG) Q4 Earnings & Sales Beat Estimates
The Procter & Gamble Company (PG - Free Report) , popularly known as P&G, reported impressive fourth-quarter fiscal 2020 results. Further, both top and bottom lines improved year over year. Results gained from a sudden spike in demand for household cleaning, personal health and cleansing products, mostly in North America and China, stemming from the ongoing COVID-19 pandemic.
Procter & Gamble’s core earnings of $1.16 per share rose 5% year over year and outpaced the Zacks Consensus Estimate of $1.01 on the back of sturdy sales growth and improved operating margin. Meanwhile, currency-neutral core earnings per share (EPS) increased 11%.
The company reported net sales of $17,698 million, increasing 4% year over year and surpassing the Zacks Consensus Estimate of $16,952 million. The company mix to net sales growth was 1% year over year.
Procter Gamble Company The Price, Consensus and EPS Surprise
Procter Gamble Company The price-consensus-eps-surprise-chart | Procter Gamble Company The Quote
Sales in Detail
On an organic basis (excluding the impact of acquisitions, divestitures and foreign exchange), revenues moved up 6% based on a 3% rise in organic shipment volume. Further, sales inched up 2% owing to higher pricing.
Moreover, all of the company’s business segments, except Grooming, reported growth in organic sales. Organic sales moved up 3% in the Beauty segment, 2% in Health Care, 14% in Fabric & Home Care and 5% in the Baby, Feminine and Family Care segment. However, the metric declined 1% in the Grooming division.
Net sales in the Fabric & Home Care, and Baby, Feminine and Family Care segments rose 11% and 3%, respectively. However, net sales in the Health Care and Grooming segments declined 1% and 5%, respectively. For the Beauty segment, sales remained flat year over year.
Margins
In the reported quarter, core gross margin expanded 210 basis points (bps) year over year to 49.5%, including 40 bps of adverse impacts of foreign currency. On a currency-neutral basis, core gross margin expanded 250 bps owing to benefits from gross productivity savings, higher pricing and commodity cost declines. The uptick was partly offset by unfavorable product mix, manufacturing and logistics expenses and other headwinds.
Core selling, general and administrative expenses (SG&A), as a percentage of sales, increased 70 bps to 29.8%. The metric expanded 50 bps on a currency-neutral basis. This can be attributable to gains from the sale of real estate, increased marketing investments, rise in costs related to wage inflation and incentive compensation. These factors were more than offset by savings related to overhead and marketing expenses.
Moreover, core operating margin expanded 140 bps. On a currency-neutral basis, the metric improved 190 bps, driven by 440 bps of total productivity cost savings.
Financials
Procter & Gamble ended the reported quarter with cash and cash equivalents of $16,181 million, long-term debt of $23,537 million and total shareholders’ equity of $46,878 million.
Cash flow from operating activities amounted to $17,403 million for fiscal 2020, with operating cash flow of $4.8 billion in the fiscal fourth quarter. Moreover, free cash flow productivity was 114%.
Furthermore, the company returned $15.2 billion of cash to its shareholders in fiscal 2020. This included dividend payouts worth $7.8 billion and share buybacks of $7.4 billion.
Fiscal 2021 Guidance
Management issued fiscal 2021 guidance. Notably, the company anticipates sales growth of 1-3%, with organic sales growth of 2-4%. Unfavorable currency is expected to affect sales by 1% in fiscal 2021. Apart from these, capital expenditure is envisioned to be 4-5% of fiscal 2021 sales.
Further, earnings on a reported basis are likely to witness growth of 6-10%. Core earnings for fiscal 2021 are projected to grow 3-7%. This view takes into account an after-tax headwind of $300 million due to currency woes, which are likely to be more than offset by a $275-million after-tax benefit related to reduced commodity costs. Also, elevated interest costs and soft interest income to the tune of $150 million are expected to hurt fiscal 2021 results.
Adjusted free cash flow productivity is estimated to be 90%. In addition to this, the company anticipates dividend payments of $8 billion and share repurchases of $6-$8 billion in fiscal 2021.
Price Performance
We note that shares of this Zacks Rank #2 (Buy) company have gained 10.4% in the past year compared with the industry’s 13.6% growth.
Other Stocks to Consider
Helen of Troy (HELE - Free Report) has a long-term earnings growth rate of 6.5% and a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Clorox Company (CLX - Free Report) has a long-term earnings growth rate of 5.9%. The stock presently carries a Zacks Rank #2.
The Kraft Heinz Company (KHC - Free Report) , with a long-term earnings growth rate of 6%, currently carries a Zacks Rank #2.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>